| Back |
|
| *******Your most confident choice for treating infections |
| Product Name: |
| Injection |
| Ceftriaxone 250/500/1000 mg |
| A commendable choice for complete relief |
| Surgical Procedures |
| * Possesses improved pharmacokinetic & pharmacodynamic properties leading to wide acceptance in surgical practice. |
| ** Superior to other antibiotics in preventing both local & remote post operative infections. |
| Neonatal Meningitis |
| * Possesses the advantage of a single daily administration & an excellent activity in cerebo-spinal fluid against susceptible bacteria |
| ** In 5 randomised trials, I.V. Ceftriaxone 60-100 mg/kg sterilised CSF in 98-100% of infants & children with meningitis within 18-36 hours |
| Acute Otitis Media - In children with acute otitis media, 3 dose regimen of I.M. Ceftriaxone 50 mg/kg/day eradicated 93-98% of middle ear pathogens |
|
| Also available: CEFDINE injection (Ceftazidime 250 mg / 1000 mg)
|
|
| Neonatal Meningitis
|
| Acute Otitis Media
|
| Post Surgical Infections
|
| Skin & soft tissue infections
|
|
Medical Jr.
| Drugs 2002; 62(7)
|
| Clin. Drug Invest 2004; 24(1)
|
| Drugs 2002; 62(7)
|
| Drugs 1999 Sep; 58(3)
|
|
| |
|
 |